Tradipitant
VP-VLY-686-3101
Phase 3 small_molecule completed
Quick answer
Tradipitant for Atopic Dermatitis is a Phase 3 program (small_molecule) at Vanda Pharmaceuticals with 3 ClinicalTrials.gov record(s).
Program details
- Company
- Vanda Pharmaceuticals
- Indication
- Atopic Dermatitis
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed